Skip to content

Pre-ERCP High Carbohydrate Drinks Improve Patients Recovery

Pre-ERCP Carbohydrate Drinks Improve Patients Recovery: an ERAS Protocol Attempts in ERCP

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03075280
Enrollment
1292
Registered
2017-03-09
Start date
2017-04-01
Completion date
2021-04-17
Last updated
2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication

Keywords

ERCP, ERAS, complication, fatigue, high carbohydrate diet

Brief summary

To test the benefits of extra high carbohydrate liquid diet uptake 2 hours before ERCP in improving patients' early recovery.

Detailed description

Enhanced recovery after surgery (ERAS) has been formed of procedure which contains preoperative education, improvement of anesthesia, reducing the number of drainage tubes, and early diet after surgery. In recent years, because of its positive advantages, ERAS was widely accepted in surgical fields. For upper gastrointestinal surgery, high-carbohydrate drinks can be given 2 hours before surgery in order to guarantee the stability of blood glucose and circulation during the operation. It obviously reduce the preoperative thirst, hunger, irritability and even the incidence of postoperative complications. However ERAS program is rarely studied in ERCP. Theoretically we can use ERAS as a strategy to reduce post-ERCP uncomfortable and complications.

Interventions

PROCEDURE400ml high carbohydrate liquid diet before ERCP

400ml high carbohydrate liquid diet uptake 2 hours before ERCP

Sponsors

Hepatopancreatobiliary Surgery Institute of Gansu Province
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* ERCP patients, * Age 18-85 years old.

Exclusion criteria

* Coagulation dysfunction (INR\> 1.3) and low peripheral blood platelet count(\<50×109 / L) or using anti-coagulation drugs, * Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease, shock, liver or kidney malfunction, * Diabetes(blood glucose fluctuations)or with complications, * Intestinal obstruction or other contraindications with feeding and watering, * Prior surgery of Bismuth Ⅱ and Roux-en-Y, * Pregnant women, * Unwillingness or inability to consent for the study.

Design outcomes

Primary

MeasureTime frameDescription
Levels of fatigue (Fatigue Scale-14 scoring system)6 monthsThe patients always feel tired and faint. The clinical manifestation includes slow to respond, the flexibility and coordination disorders.
Abdominal pain6 monthsPain score (scores:1-10)

Secondary

MeasureTime frameDescription
Postoperative abdominal distention6 monthsDistention uncomfortable
Postoperative nausea and vomiting6 monthsNausea or vomiting after procedure
Complications6 monthsPancreatitis, cholangitis, bleeding, aspiration, et,al.
The average incubation time6 monthsThe time of total procedure
Intraoperative residues in stomach6 monthsThe volume of stomach residues
The time eating6 monthsThe time of eager to eat after procedure
Length of hospital stay6 monthsDays of hospital stay
Blood glucose6 monthsIntra-operative blood glucose and 2 hours' blood glucose after procedure
Successful cannulation time6 monthsFrom first achieve the papilla to success cannulation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026